Hepatitis B virus DNA (HBV-DNA) serves as a crucial biomarker for the detection of the hepatitis B virus, with variations in its concentration in blood samples providing vital insights into patient infection and recovery status. We have developed an electrochemical biosensor tailored for HBV-DNA detection, exhibiting high sensitivity, specificity, and a broad detection range. The biosensor utilizes a composite material composed of MXene and multiwalled carbon nanotubes (MX/MWCNTs), prepared through a hand-shaking self-assembly technique, to modify the glassy carbon electrode (GCE) and serve as signal receivers. A meticulously designed padlock probe DNA specifically recognizes HBV-DNA and forms a double-stranded DNA structure, which is subsequently degraded by exonuclease III. The resulting sequence then hybridizes with a PolyT-primer to create template, triggering rolling circle amplification and releasing a substantial amount of pyrophosphate for the initial level of signal amplification. Subsequently, the pyrophosphate induces the release of methylene blue (MB) from MB@ZIF-90 composite, achieving a second level of signal amplification. The released MB is then adsorbed by the MX/MWNCNTs-modified GCE, which possesses cationic dye adsorption capabilities and a large specific surface area, generating a detection signal and completing the third level of amplification. This biosensor offers a detection range spanning from 1.0 pM to 1.0 × 106 pM, with a remarkable detection limit as low as 0.5 pM (3σ/S), and is capable of distinguishing base mismatches. Furthermore, it has demonstrated excellent specificity and recovery performance in serum testing. The performance of this biosensor demonstrates significant potential for clinical application, with the ultimate goal of improving the diagnosis and management of hepatitis B.Graphical
Read full abstract